Paulson & Co. - Q1 2017 holdings

$7.53 Billion is the total value of Paulson & Co.'s 100 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 54.9% .

 Value Shares↓ Weighting
AGN SellALLERGAN PLC$702,863,000
-5.8%
2,941,834
-17.2%
9.33%
-0.9%
SHPG SellSHIRE PLCsponsored adr$696,589,000
-2.8%
3,998,100
-4.9%
9.25%
+2.4%
MYL SellMYLAN N V$673,528,000
-14.3%
17,274,387
-16.2%
8.94%
-9.8%
GLD  SPDR GOLD TRUST$517,586,000
+8.3%
4,359,7220.0%6.87%
+14.1%
TEVA SellTEVA PHARMACEUTICAL INDS LTDsponsored adr$352,903,000
-38.9%
10,997,300
-30.9%
4.68%
-35.6%
MNKKQ SellMALLINCKRODT PUB LTD CO$334,318,000
-15.9%
7,500,972
-6.0%
4.44%
-11.4%
STAY SellEXTENDED STAY AMER INCunit 99/99/9999b$318,573,000
-30.0%
20,086,590
-29.8%
4.23%
-26.3%
TWX BuyTIME WARNER INC$295,475,000
+7.2%
3,024,000
+5.9%
3.92%
+12.9%
AIG SellAMERICAN INTL GROUP INC$283,969,000
-9.6%
4,548,593
-5.4%
3.77%
-4.8%
TMUS NewT MOBILE US INC$267,409,0004,140,100
+100.0%
3.55%
DISH NewDISH NETWORK CORPcl a$219,047,0003,450,100
+100.0%
2.91%
VRX  VALEANT PHARMACEUTICALS INTL$213,811,000
-24.0%
19,384,5000.0%2.84%
-20.0%
AKRXQ SellAKORN INC$202,202,000
+6.6%
8,397,100
-3.3%
2.68%
+12.3%
CACQ  CAESARS ACQUISITION COcl a$202,017,000
+14.1%
13,117,9980.0%2.68%
+20.1%
RLGY  REALOGY HLDGS CORP$142,545,000
+15.8%
4,785,0000.0%1.89%
+21.9%
CZR  CAESARS ENTMT CORP$137,691,000
+12.4%
14,417,9000.0%1.83%
+18.3%
AU  ANGLOGOLD ASHANTI LTDsponsored adr$137,666,000
+2.5%
12,782,4000.0%1.83%
+7.9%
NXPI BuyNXP SEMICONDUCTORS N V$117,193,000
+220.6%
1,132,300
+203.6%
1.56%
+237.3%
SGYPQ  SYNERGY PHARMACEUTICALS DEL$112,253,000
-23.5%
24,088,6550.0%1.49%
-19.4%
NG SellNOVAGOLD RES INC$107,776,000
+6.1%
22,130,696
-0.6%
1.43%
+11.8%
MJN BuyMEAD JOHNSON NUTRITION CO$105,489,000
+4741.2%
1,184,200
+3744.8%
1.40%
+5085.2%
TSU SellTIM PARTICIPACOES S Asponsored adr$89,678,000
+33.9%
5,611,900
-1.1%
1.19%
+41.0%
ENDP SellENDO INTL PLC$87,482,000
-32.2%
7,838,900
-0.0%
1.16%
-28.6%
OASPQ SellOASIS PETE INC NEW$73,532,000
-6.4%
5,156,544
-0.6%
0.98%
-1.4%
BACWSA  BANK OF AMERICA CORPORATION* w exp 01/16/2019$70,778,000
+13.6%
6,263,5260.0%0.94%
+19.6%
INSW SellINTERNATIONAL SEAWAYS INC$70,214,000
+35.9%
3,672,279
-0.2%
0.93%
+43.2%
WLH  LYON WILLIAM HOMEScl a new$68,513,000
+8.4%
3,322,6660.0%0.91%
+14.1%
BKD NewBROOKDALE SR LIVING INC$67,707,0005,041,500
+100.0%
0.90%
ODP SellOFFICE DEPOT INC$66,542,000
-3.5%
14,264,100
-6.5%
0.88%
+1.6%
 COBALT INTL ENERGY INCnote 3.125% 5/15/2024$54,807,000
-10.7%
219,229,0000.0%0.73%
-6.1%
ALXN BuyALEXION PHARMACEUTICALS INC$40,518,000
+116.0%
334,200
+117.9%
0.54%
+128.0%
GOLD SellRANDGOLD RES LTDadr$37,679,000
-1.3%
431,700
-13.7%
0.50%
+4.0%
WWAV SellWHITEWAVE FOODS CO$37,621,000
+0.0%
670,000
-0.9%
0.50%
+5.3%
ENZY  ENZYMOTEC LTD$37,013,000
+34.4%
4,205,9800.0%0.49%
+41.5%
LOXO SellLOXO ONCOLOGY INC$34,190,000
+28.5%
812,500
-1.9%
0.45%
+35.5%
AEM SellAGNICO EAGLE MINES LTD$32,153,000
-29.2%
757,600
-29.9%
0.43%
-25.3%
STE BuySTERIS PLC$29,416,000
+39.2%
423,500
+35.1%
0.39%
+46.6%
THM  INTERNATIONAL TOWER HILL MIN$29,131,000
-5.8%
55,487,8420.0%0.39%
-0.8%
FB BuyFACEBOOK INCcl a$26,322,000
+26.4%
185,300
+2.4%
0.35%
+33.2%
L100PS NewARCONIC INC$25,900,000983,300
+100.0%
0.34%
ALXN  ALEXION PHARMACEUTICALS INCcall$24,248,000
-0.9%
200,0000.0%0.32%
+4.5%
SHPG SellSHIRE PLCcall$22,650,000
-16.9%
130,000
-18.8%
0.30%
-12.5%
DXCM SellDEXCOM INC$20,395,000
+16.5%
240,700
-17.9%
0.27%
+22.6%
TIME SellTIME INC NEW$19,000,000
+7.3%
981,900
-1.0%
0.25%
+13.0%
PANW NewPALO ALTO NETWORKS INC$17,556,000155,800
+100.0%
0.23%
GSK BuyGLAXOSMITHKLINE PLCsponsored adr$17,501,000
+53.5%
415,100
+40.2%
0.23%
+61.1%
CIE SellCOBALT INTL ENERGY INC$16,506,000
-56.5%
30,944,127
-0.5%
0.22%
-54.2%
EBAY SellEBAY INC$15,818,000
-14.4%
471,200
-24.3%
0.21%
-9.9%
IAG  IAMGOLD CORP$15,456,000
+3.9%
3,863,9120.0%0.20%
+9.6%
PFE BuyPFIZER INC$13,941,000
+21.9%
407,500
+15.7%
0.18%
+28.5%
SNAP NewSNAP INCput$13,067,000580,000
+100.0%
0.17%
SD BuySANDRIDGE ENERGY INC$12,324,000
+113.6%
666,535
+172.0%
0.16%
+124.7%
FGL NewFIDELITY & GTY LIFE$11,120,000400,000
+100.0%
0.15%
XENT NewINTERSECT ENT INC$10,978,000640,100
+100.0%
0.15%
FDX BuyFEDEX CORP$9,660,000
+371.7%
49,500
+350.0%
0.13%
+392.3%
GOOG SellALPHABET INCcap stk cl c$9,291,000
-44.5%
11,200
-48.4%
0.12%
-41.7%
ETSY SellETSY INC$8,855,000
-40.7%
833,000
-34.3%
0.12%
-37.2%
SYMX  SYNTHESIS ENERGY SYS INC$8,520,000
-14.8%
10,000,0000.0%0.11%
-10.3%
BACWSB  BANK OF AMERICA CORPORATION* w exp 10/28/2018$8,194,000
-4.4%
8,928,3440.0%0.11%
+0.9%
ESPR BuyESPERION THERAPEUTICS INC NE$8,185,000
+541.0%
231,800
+127.3%
0.11%
+581.2%
RAI BuyREYNOLDS AMERICAN INC$7,941,000
+33.7%
126,000
+18.9%
0.10%
+40.0%
MYL SellMYLAN N Vcall$7,798,000
-77.4%
200,000
-77.9%
0.10%
-76.1%
WBMD NewWEBMD HEALTH CORP$7,665,000145,500
+100.0%
0.10%
SNY SellSANOFIsponsored adr$6,788,000
-33.7%
150,000
-40.7%
0.09%
-30.2%
NSR  NEUSTAR INCcl a$6,630,000
-0.7%
200,0000.0%0.09%
+4.8%
TMQ SellTRILOGY METALS INC NEW$6,370,000
+8.3%
11,584,373
-0.2%
0.08%
+14.9%
MELI SellMERCADOLIBRE INC$5,794,000
-3.4%
27,400
-28.6%
0.08%
+1.3%
ISRG SellINTUITIVE SURGICAL INC$5,672,000
-11.4%
7,400
-26.7%
0.08%
-7.4%
Z NewZILLOW GROUP INCcl c cap stk$5,606,000166,500
+100.0%
0.07%
COR SellCORESITE RLTY CORP$5,421,000
-46.7%
60,200
-53.0%
0.07%
-43.8%
KMDA  KAMADA LTD$4,969,000
+24.8%
730,8000.0%0.07%
+32.0%
AMZN NewAMAZON COM INC$4,876,0005,500
+100.0%
0.06%
BIIB SellBIOGEN INC$4,730,000
-68.0%
17,300
-66.9%
0.06%
-66.3%
SERV NewSERVICEMASTER GLOBAL HLDGS I$4,760,000114,000
+100.0%
0.06%
TEAM NewATLASSIAN CORP PLCcl a$4,715,000157,415
+100.0%
0.06%
MBBYF NewMOBILEYE N V AMSTELVEEN$4,666,00076,000
+100.0%
0.06%
MON NewMONSANTO CO NEW$4,019,00035,500
+100.0%
0.05%
NVDQ  NOVADAQ TECHNOLOGIES INCput$3,895,000
+15480.0%
500,0000.0%0.05%
CYH SellCOMMUNITY HEALTH SYS INC NEWput$3,016,000
-66.3%
340,000
-78.8%
0.04%
-64.6%
BCRX  BIOCRYST PHARMACEUTICALScall$2,940,000
+32.7%
350,0000.0%0.04%
+39.3%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$2,755,000
+301.0%
463,000
+166.1%
0.04%
+311.1%
SRPT NewSAREPTA THERAPEUTICS INC$2,312,00078,101
+100.0%
0.03%
HW NewHEADWATERS INC$2,348,000100,000
+100.0%
0.03%
KTWO NewK2M GROUP HLDGS INC$1,979,00096,500
+100.0%
0.03%
RIGL BuyRIGEL PHARMACEUTICALS INC$1,821,000
+97.3%
550,000
+41.9%
0.02%
+100.0%
INSM SellINSMED INC$1,576,000
-42.0%
90,000
-56.1%
0.02%
-38.2%
TRVN NewTREVENA INC$1,496,000407,626
+100.0%
0.02%
ALDR  ALDER BIOPHARMACEUTICALS INC$1,539,0000.0%74,0000.0%0.02%
+5.3%
CNCE NewCONCERT PHARMACEUTICALS INC$1,198,00070,229
+100.0%
0.02%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$1,099,00050,500
+100.0%
0.02%
NTLA NewINTELLIA THERAPEUTICS INC$1,107,00078,600
+100.0%
0.02%
EDIT NewEDITAS MEDICINE INC$1,116,00050,000
+100.0%
0.02%
TNDM NewTANDEM DIABETES CARE INC$600,000500,000
+100.0%
0.01%
PBYI  PUMA BIOTECHNOLOGY INC$584,000
+21.2%
15,6900.0%0.01%
+33.3%
MULE NewMULESOFT INCcl a added$487,00020,000
+100.0%
0.01%
ARDMQ  ARADIGM CORP$299,000
-2.9%
192,7270.0%0.00%0.0%
OSG SellOVERSEAS SHIPHOLDING GROUP Icl a new added$174,000
-36.5%
45,139
-37.0%
0.00%
-33.3%
ARCC NewARES CAP CORP$01
+100.0%
0.00%
LILA ExitLIBERTY GLOBAL PLC$0-4,990
-100.0%
-0.00%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-70,800
-100.0%
-0.00%
BCRX ExitBIOCRYST PHARMACEUTICALS$0-52,600
-100.0%
-0.00%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-19,300
-100.0%
-0.01%
AKAOQ ExitACHAOGEN INC$0-72,500
-100.0%
-0.01%
RTRX ExitRETROPHIN INC$0-55,000
-100.0%
-0.01%
WCIC ExitWCI CMNTYS INC$0-70,000
-100.0%
-0.02%
SHOP ExitSHOPIFY INCcl a$0-40,700
-100.0%
-0.02%
DG ExitDOLLAR GEN CORP NEW$0-29,600
-100.0%
-0.03%
CBOE ExitCBOE HLDGS INC$0-38,412
-100.0%
-0.04%
GPRO ExitGOPRO INCput$0-400,000
-100.0%
-0.04%
FCH ExitFELCOR LODGING TR INC$0-500,000
-100.0%
-0.05%
BSX ExitBOSTON SCIENTIFIC CORP$0-288,000
-100.0%
-0.08%
HCA ExitHCA HOLDINGS INC$0-111,600
-100.0%
-0.10%
ExitSANDRIDGE ENERGY INCnote 10/0$0-7,906,627
-100.0%
-0.13%
WDAY ExitWORKDAY INCcl a$0-173,900
-100.0%
-0.14%
P ExitPANDORA MEDIA INCput$0-990,000
-100.0%
-0.16%
LIVN ExitLIVANOVA PLC$0-310,000
-100.0%
-0.18%
ACAS ExitAMERICAN CAP LTD$0-865,868
-100.0%
-0.20%
WEN ExitWENDYS COput$0-1,250,000
-100.0%
-0.21%
ExitCOBALT INTL ENERGY INCnote 2.625%12/0$0-45,260,000
-100.0%
-0.22%
ALXN ExitALEXION PHARMACEUTICALS INCput$0-153,000
-100.0%
-0.24%
ATVI ExitACTIVISION BLIZZARD INC$0-968,000
-100.0%
-0.44%
AGN ExitALLERGAN PLCcall$0-214,700
-100.0%
-0.57%
TTWO ExitTAKE-TWO INTERACTIVE SOFTWAR$0-967,900
-100.0%
-0.60%
DVMT ExitDELL TECHNOLOGIES INC$0-1,090,104
-100.0%
-0.76%
HPE ExitHEWLETT PACKARD ENTERPRISE C$0-2,976,400
-100.0%
-0.87%
VMW ExitVMWARE INC$0-992,200
-100.0%
-0.98%
BEAV ExitB/E AEROSPACE INC$0-1,316,500
-100.0%
-1.00%
HAR ExitHARMAN INTL INDS INC$0-853,800
-100.0%
-1.20%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

About Paulson & Co.

Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.

John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.

Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.

In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RESOURCES INC42Q3 202312.0%
INTERNATIONAL TOWER HILL MINE42Q3 20233.4%
IAMGOLD CORP42Q3 20230.5%
ANGLOGOLD ASHANTI-SPON ADR41Q2 20237.9%
AGNICO EAGLE MINES LTD34Q3 20233.8%
SPDR GOLD TRUST33Q1 202213.3%
TRILOGY METALS INC NEW29Q3 20230.9%
ENDO INTL PLC28Q2 20223.4%
CAESARS ENTMT CORP27Q4 20194.6%
TIM PARTICIPACOES SA-ADR26Q3 20202.4%

View Paulson & Co.'s complete holdings history.

Latest significant ownerships (13-D/G)
Paulson & Co. Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Thryv Holdings, Inc.February 14, 20232,000,0005.8%
Endo International plcFebruary 14, 202217,327,0127.4%
BrightSphere Investment Group Inc.December 22, 20218,950,12119.8%
PERPETUA RESOURCES CORP.August 27, 202120,929,28033.3%
Bausch Health Companies Inc.May 15, 202025,839,0357.3%
OVERSEAS SHIPHOLDING GROUP INCApril 13, 20206,300,0007.3%
SYNTHESIS ENERGY SYSTEMS INCFebruary 14, 2020165,64810.5%
Callon Petroleum CoNovember 18, 201910,338,6634.5%
International Seaways, Inc.July 03, 20191,459,1195.0%
AKORN INCSold outFebruary 14, 201800.0%

View Paulson & Co.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-01-22
SC 13D/A2024-01-22
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14

View Paulson & Co.'s complete filings history.

Compare quarters

Export Paulson & Co.'s holdings